ESG Report 2020

Product Labelling and Description The Group has formulated and implemented drug quality due to improper transportation and relevant management systems for label packaging storage. Besides, package inserts must contain materials in accordance with laws and regulations. details of the pharmaceutical's directions, data All package inserts and labels comply with the and information showing its safety, effectiveness requirements in the Provisions on the and adverse drug reactions, so as to guide users Administration of Pharmaceutical Directions and to take the pharmaceuticals correctly and Labels and are subject to examination, filing and reasonably. The Group will constantly monitor the approval by the National Medical Products use of the pharmaceuticals, and will submit Administration. applications to the National Medical Products Administration to amend package inserts when The Group has formulated internal policies, necessary, so as to provide users with the best stipulating that pharmaceutical labels and package pharmaceutical information and description. inserts must meet relevant requirements. Pharmaceutical labels must itemise the drug At the same time, the Group has also set up name, ingredients, use of drug, directions and management procedures for plate making, printing, dosage, production date and other relevant and acceptance of product labels, manuals, and information to let users understand the usage and printed packaging materials. The Quality risks of the pharmaceuticals. Apart from Management Department will carry out pharmaceutical labels, the Group also formulates acceptance and inspection work at every step, requirements for packaging labels on from the drafting, sample printing to printing of transportation, storage use and active product labels, manuals and packaging materials. pharmaceutical ingredients. For example, such This ensures that all the materials will be put into packaging labels must indicate the pharmaceutical the factories for use without errors, and minimises name, number of packages, expiration date, the possibility of product quality problems caused storage and transportation precautions and other by printing errors. necessary information to avoid incidents affecting Product Marketing and Promotion Pharmaceutical sale is a key sector of the Group's light of this, the Group regulates the distribution business, while requirements for pharmaceutical and promotion of pharmaceuticals in strict promotion information are much higher and more accordance with relevant laws and regulations. stringent than those of general commodities. In Product Marketing and Promotion Advertising Law of the People s Republic of China Standards for the Examination and Publication of Drug Advertisements Measures for the Examination of Drug Advertisements ’ The Group has formulated relevant systems that preparation sales distributor or distributor clearly enumerate the Group's advertising management system, which is implemented by the requirements, application procedures of Credit Risk Management Department to reduce the advertisement and promotion data feed, risk of bringing a negative reputation to the Group precautions for use, etc. All pharmaceutical during the process. When selecting new dealers or promotion information released by the Group is distributors, the Group will evaluate the company's based on scientific evidence, complies with the qualifications, storage conditions, business scope principles of accuracy, objectivity, and permits and other criteria, and sign sales contracts completeness, and contains corresponding with qualified dealers or distributors. The storage package inserts to clarify the correct medication conditions of dealers or distributors must strictly methods. All these comply with legal requirements. comply with the pharmaceuticals storage In order to ensure that the Group's advertisements conditions and requirements stated in the manuals comply with relevant laws and regulations, the for storage and use. At the same time, when samples of the advertising materials must be quality problems emerge, they must cooperate submitted to the Group's Audit and Legal Affairs with the Group to report and investigate the Department for review before being released. problem, collect evidence, and carry out follow-up work to guarantee the quality of products. The Group has established a pharmaceutical ’ Realm Relevant Laws and Regulations 41 Environmental, Social and Governance Report 2020 The United Laboratories International Holdings Limited